Senior Consultant
Fergus Kennedy
Fergus joined Eradigm in 2017 and during his time with us has developed deep knowledge across an extensive range of projects, business functions and therapeutic categories. His expertise includes cross-portfolio and cross-functional strategy, external innovation, pricing and reimbursement, product launch excellence and commercial opportunity assessment.
He has worked in therapeutic areas ranging from oncology, hematology and vaccines to rare diseases, immunology and neuroscience and his technological expertise encompasses cell & gene therapy, new drug modalities, digital health, POC diagnostics and biologics.
Fergus’s consultancy experience has been gained in both entrepreneurial and strategic roles. Previous positions include business development roles for MedImmune/AstraZeneca, analytics roles for GSK and spells working in consultancy for both Cambridge Enterprise and Owlstone Medical. He holds a first class degree in Biology from the University of Oxford and a Masters in Bioscience Enterprise from the University of Cambridge.
Outside of work, Fergus is keen cook and baker and loves all things ‘foodie’, as well as travel, creative writing, film and music. He is also an avid reader of, and listener to, anything related to science, technology, economics and sociology.